or Try an Advanced Search...

    Technical Analysis for TCRT - Alaunos Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 1.32 1.54% 0.02
    TCRT closed up 1.54 percent on Wednesday, May 8, 2024, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical TCRT trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Earnings Movers Other 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish 1.54%
    Wide Bands Range Expansion 1.54%
    20 DMA Resistance Bearish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Older End-of-Day Signals for TCRT ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 11 hours ago
    Possible NR7 about 12 hours ago
    Possible Inside Day about 12 hours ago
    Fell Below 10 DMA about 13 hours ago
    Rose Above 20 DMA about 14 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    TCRT Chart by TradingView
    Basic chart:

    Profile

    Alaunos is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR. The Company has clinical and strategic collaborations with The University of Texas MD Anderson Cancer Center and the National Cancer Institute.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cell Therapy Epidermal Growth Factor Receptor Oncogenes National Cancer Institute P53 Tumor Suppressor Genes Mm 151 Ras Gtpase University Of Texas Md Anderson Cancer Center

    Is TCRT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Dec 19 Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Nov 14 Recap: Alaunos Therapeutics Q3 Earnings
    Nov 14 Alaunos Therapeutics GAAP EPS of -$0.04 in-line
    Nov 14 Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
    See more TCRT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.47
    52 Week Low 0.6615
    Average Volume 58,743
    200-Day Moving Average 2.00
    50-Day Moving Average 1.63
    20-Day Moving Average 1.30
    10-Day Moving Average 1.30
    Average True Range 0.15
    RSI (14) 43.82
    ADX 28.62
    +DI 14.95
    -DI 24.14
    Chandelier Exit (Long, 3 ATRs) 1.32
    Chandelier Exit (Short, 3 ATRs) 1.42
    Upper Bollinger Bands 1.58
    Lower Bollinger Band 1.02
    Percent B (%b) 0.54
    BandWidth 42.40
    MACD Line -0.09
    MACD Signal Line -0.12
    MACD Histogram 0.028
    Fundamentals Value
    Market Cap 21.18 Million
    Num Shares 16 Million
    EPS -2.25
    Price-to-Earnings (P/E) Ratio -0.59
    Price-to-Sales 2277.94
    Price-to-Book 2.70
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.41
    Resistance 3 (R3) 1.41 1.38 1.40
    Resistance 2 (R2) 1.38 1.36 1.38 1.39
    Resistance 1 (R1) 1.35 1.34 1.37 1.35 1.38
    Pivot Point 1.32 1.32 1.33 1.32 1.32
    Support 1 (S1) 1.29 1.30 1.31 1.29 1.26
    Support 2 (S2) 1.26 1.28 1.26 1.25
    Support 3 (S3) 1.23 1.26 1.25
    Support 4 (S4) 1.23